Meng Cao

Association of MTHFR C 677 T and A 1298 C polymorphisms with the development of type 2 diabetic nephropathy and their interaction with environmental factors

Jie Hai, Qinggui Zhang, Di Wang, 2017 .

Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.

T. Wang, Jie Hai, Jianling Wang, 2015, International journal of clinical and experimental pathology.

Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development

Jie Hai, Xuehui Chen, Hua Peng, 2013, Endocrine.

Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool.

Yun Xu, Tao Wang, Yan Qin, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Association of GSTs polymorphisms with risk of gestational diabetes mellitus.

Shaoru Li, Qinggui Zhang, Di Wang, 2015, International journal of clinical and experimental pathology.

Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway.

Yongli Zhang, Sujuan Pei, Yongxiang Zhang, 2013, International immunopharmacology.

Circ_0123996 promotes the proliferation, inflammation, and fibrosis of mesangial cells by sponging miR‐203a‐3p to upregulate SOX6 in diabetic nephropathy

Yunfeng Zhu, Yan Qin, Hua Peng, 2022, Journal of biochemical and molecular toxicology.

miRNA-33 expression and its mechanism in patients and model rats with type 2 diabetic nephropathy

Di Wang, Liwei Bai, Q. Zhai, 2018 .

Antidiabetic and Nephroprotective Effects of Polysaccharide Extract from the Seaweed Caulerpa racemosa in High Fructose-Streptozotocin Induced Diabetic Nephropathy

O. Olatunji, A. Famurewa, Yan Li, 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.